Celebrex Ad Prompts Criticism From Consumer Group
This article was originally published in The Pink Sheet Daily
Executive Summary
Public Citizen urges FDA to order Pfizer to stop “dangerous” and “misleading” direct-to-consumer ad.
You may also be interested in...
Pfizer Will Highlight Celebrex Safety In ’07
Firm to address cardiovascular safety for the COX-2 inhibitor in a new DTC advertising campaign.
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.